Scholars Central

Case reportPublished 31 Oct 2022

Anti-Interleukin-6 Receptor Antagonist in Drug-Induced Therapy for Serious SARS-CoV-2 Pneumonia

Authors: Yang Siyuan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Acute respiratory distress syndrome (ARDS) is a disorder that involves the activation of alveolar macrophages triggering the innate immune system. The parenchymal lung injury seen in ARDS is a result of many proinflammatory elevations including Interleukin-6. There remains no effective standard of care of ARDS, and current treatments at this time currently do not target the immunological mechanisms or pathways involved. Treatments involving this pathway should be further investigated as targeted treatment. We discuss a case of a patient with multiple myeloma who was hospitalized with drug-induced ARDS who had a rapid response to an anti-interleukin-6 monoclonal antibody.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Medicinal and Organic Chemistry
  • SubjectChemistry
  • BylineArticles whose byline prints “Yang Siyuan”